Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Efficacy and Survival Prediction Analysis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis

NCT07437638 is registered in ClinicalTrials.gov with The Second Affiliated Hospital of Chongqing Medical University as lead sponsor.

NCT NCT07437638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07437638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Efficacy and Survival Prediction Analysis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis
Lead sponsor
The Second Affiliated Hospital of Chongqing Medical University
Phase
Observational
Overall status
Active, not recruiting
Start date
September 1, 2024
Completion date
April 5, 2026
Enrollment
624 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic encephalopathy, liver cirrhosis, tips